1H-MRS assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice

Journal of Molecular Neuroscience

Volumn 50, Issue 3, 2013, Pages 434-442

  Zhang, Wei ^a   Wang, Pei Jun ^a   Li, Ming Hua ^a   Wang, Guo Liang ^a   Li, Ping ^a   Gao, Xiao Long ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Alzheimer's disease (AD); Brain derived neurotrophic factor (BDNF); Infusion; Magnetic resonance spectroscopy (MRS); Receptor tropomyosin related kinase B (TrkB)

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INOSITOL; N ACETYLASPARTIC ACID; TROPOMYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MOUSE; NEUROIMAGING; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; SUPPLEMENTATION;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ASPARTIC ACID; BRAIN-DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; INFUSIONS, INTRAVENTRICULAR; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, TRANSGENIC; PRESENILIN-1; RECEPTOR, TRKB;

MUS; MUS MUSCULUS;

EID: 84878907066     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-9951-5     Document Type: Article

References (38)

1. Abraham CR (2001) Reactive astrocytes and alpha1-antiehymotrypsin in Alzheimer's disease. Neurobiol Aging 22(6):931-936
2. Behar KL, den Hollander JA, Stromski ME, Ogino T, Shulman RG, Petroff OA, Prichard JW (1983) High resolution 1H-MRS study of cerebral hypoxia in vivo. Proc Natl Acad Sci USA 80(16):4945-4948
3. Blurton-Jones M, Kitazawa M, Martinez-Coria H, Castello NA, Müller FJ, Loring JF, Yamasaki TR, Poon WW, Green KN, LaFerla FM (2009) Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proc Natl Acad Sci U S A 106(32):13594-13599
4. Chen SQ, Wang PJ, Ten GJ, Zhan W, Li MH, Zang FC (2009) Role of myo-inositol by magnetic resonance spectroscopy in early diagnosis of Alzheimer's disease in APP/PS1 transgenic mice. Dement Geriatr Cogn Disord 28(6):558-566
5. Choi JK, Carreras I, Dedeoglu A, Jenkins BG (2010) Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models. Neuropharmacology 59(4-5):353-357
6. Cummings JL (2003) Alzheimer's disease: from molecular biology to neuropsychiatry. Semin Clin Neuropsychiatry 8(1):31-36
7. den Heijer T, Sijens PE, Prins ND, Hofman A, Koudstaal PJ, Oudkerk M, Breteler MM (2006) MR spectroscopy of brain white matter in the prediction of dementia. Neurology 66(4):540-544
8. Elliott RC, Black IB, Dreyfus CF (2001) Dregfus, Differential regulation of p75 and trkB mRNA expression after depolarizing stimuli or BDNF treatment in basal forebrain neuron cultures. J Neurosci Res 66(1):83-88
9. Falini A, Bozzali M, Magnani G, Pero G, Gambini A, Benedetti B, Mossini R, Franceschi M, Comi G, Scotti G, Filippi M (2005) A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment. NeuroImage 26(4):1159-1163
10. Garzon D, Yu G, Fahnestock M (2002) Fahnestock M. A new brain-derived neurotrophic factor transcript and decrease in brain-derived neurotrophie factor transcripts 1, 2 and 3 in Alzheimer's disease parietal cortex. J Neurochemistry 82(5):1058-1064
11. Jankowsky JL, Slunt HH, Gonzales V, Jenkins NA, Copeland NG, Borchelt DR (2004) APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol Aging 25(77):885-892
12. Jellinger KA (2006) Alzheimer 100-highlights in the history of Alzheimer research. J Neural Transm 113(11):1603-1623
13. Jessen F, Traeber F, Freymann K, Maier W, Schild HH, Block W (2006) Treatment monitoring and response prediction with proton MR spectroscopy in AD. Neurology 67(3):528-530
14. Jones RS, Waldman AD (2004) 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia. Neurol Res 26(5):488-495
15. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Tang-Wai DF, O'Brien PC, Weigand SD, Edland SD, Smith GE, Ivnik RJ, Ferman TJ, Tangalos EG, Jack CR Jr (2004) 1H MR spectroscopy in common dementias. Neurology 63(8):1393-1398
16. Karlawish JH, Casarett DJ, James BD, Xie SX, Kim SY (2005) The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment. Neurology 64(9):1514-1519
17. Klein RL, Muir D, King MA, Peel AL, Zolotukhin S, Möller JC, Krüttgen A, Heymach JV Jr, Muzyczka N, Meyer EM (1999) Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and TrK receptor levels in the adult rat basal forebrain. Neuroscience 90(3):815-821
18. Kiyota T, Ingraham KL, Jacobsen MT, Xiong H, Ikezu T (2011) FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders. Proc Natl Acad Sci U S A 108(49):E1339-1348
19. Laske C, Stransky E, Leyhe T, Eschweiler GW, Wittorf A, Richartz E, Bartels M, Buchkremer G, Schott K (2006) Stage-dependent BDNF serum concentrations in Alzheimer's disease. J Neural Transm 113(9):1217-1224
20. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR Jr, Ugurbil K, Garwood M (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 102(33):11906-11910
21. Mrak RE, Sheng JG, Griffin WS (1996) Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer' disease. J Neuropathol Exp Neurol 55(33):273-279
22. Modrego PJ, Fayed N, Errea JM, Rios C, Pina MA, Sarasa M (2010) Memantine versus donepezil in mild to moderate Alzheimer's disease: a randomized trial with magnetic resonance spectroscopy. Eur J Neurol 17(3):405-412
23. Murer MG, Yan Q, Raisman-Vozari R (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63(1):71-124
24. Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, Chiba AA, Tuszynski MH (2009) Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nat Med 15(3):331-337
25. Parihar MS, Hemnani T (2004) Alzheimer's disease pathogenesis and therapeutic interventions. J Clin Neurosci 11(5):456-467
26. Peng S, Wuu J, Mufson EJ, Fahnestock M (2005) Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J Neurochem 93(6):1412-1421
27. Selkoe DJ (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 81(2):741-766
28. Soares DP, Law M (2009) Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications. Clin Radiol 64(1):12-21
29. Schmued LC, Albertson C, Slikker W Jr (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751(1):37-46
30. Schmued LC, Hopkins KJ (2000) Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874(2):123-130
31. Schaeffer EL, Novaes BA, da Silva ER, Skaf HD, Mendes-Neto AG (2009) Strategies to promote differentiation of newborn neurons into mature functional cells in Alzheimer brain. Prog Neuro-Psychopharmacol Biol Psychiatry 33(7):1087-1102
32. Tuszynski MH, Thal L, Pay M, Salmon DP, Hoi Sang U, Bakay R, Patel P, Blesch A, Vahlsing HL, Ho G, Tong G, Potkin SG, Fallon J, Hansen L, Mufson EJ, Kordower JH, Gall C, Conner J (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11(5):551-555
33. Valenzuela MJ, Sachdev P (2001) Magnetic resonance spectroscopy in AD. Neurology 56(5):592-598
34. Woo DC, Lee SH, Lee DW, Kim SY, Kim GY, Rhim HS, Choi CB, Kim HY, Lee CU, Choe BY (2010) Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS. Behav Brain Res 211(1):125-131
35. Youdim MB, Buccafusco JJ (2005) Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. Trends Pharmacol Sci 26(1):27-35
36. Yamamoto M, Horiba M, Buescher JL, Huang D, Gendelman HE, Ransohoff RM, Ikezu T (2005) Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta amyloid deposition. Am J Pathol 166(5):1475-1485
37. Xuan AG, Long DH, Gu HG, Yang DD, Hong LP, Leng SL (2008) Protective effects of transplanted neural stem cells on the brain of Alzheimer's disease rats. Neurosci Lett 440(3):331-335
38. Zarranz J (2004) From empiricism to neuroscience in Alzheimer's disease. Rev Neurol 39(6):576-582